Chronic Obstructive Pulmonary Disease and Comorbidities
阅读次数: 发布日期:2013-06-14
Chronic Obstructive Pulmonary Disease and Comorbidities |
2013-07-03
Language: English
The George Institute for Global Health at Peking University Health Science Center
Seminar Room, Horizon, B1801, No.6 Zhichun Rd, Haidian District, Beijing
北京大学医学部乔治健康研究所培训室, 北京海淀区知春路6号锦秋国际大厦B1801室(学知桥西200米路南)
Norbert Berend, AM MB BS MD FRACP MAICD
Professor Emeritus at the University of Sydney,
Head of Respiratory Research at the George Institute for Global Health,
Sydney, Australia
About the speaker
Professor Berend holds visiting and honorary professorships at 3 Chinese universities. He has a strong research background with the latest NHMRC grant being conducted entirely in China. His administrative experience extends to having been Head of the Department of Respiratory Medicine at the Royal North Shore Hospital in Sydney, Executive Director of the Royal North Shore Hospital, and serving as Director of the Woolcock Institute of Medical Research for 12 years, a position from which he retired in June 2012. He is a graduate of the Australian Institute of Company Directors. He has been heavily involved in national and international respiratory societies having been President of the Thoracic Society of Australia and New Zealand and the Asia Pacific Society of Respirology. He has also served on the Council of the European Respiratory Society and has been a member of the Board of the American Thoracic Society. In 2003, Norbert was made a Member of the Order of Australia for service to respiratory medicine as a researcher, administrator and educator. In 2011, he was Chairman of the Forum of International Respiratory Societies. In 2012, Norbert was given an Award of Merit and made an Honorary Member of the European Respiratory Society in recognition of outstanding contributions to the development of respiratory medicine.
About the lecture
It is known that Chronic Obstructive Pulmonary Disease (COPD) is associated with increased hypertension, cardiovascular disease, diabetes, osteoporosis, muscle weakness and a number of other conditions. These comorbidities have traditionally been regarded as coexistent medical conditions but increasingly they are now being regarded as causally related to COPD. These comorbidities have an important effect on the quality of life, morbidity and mortality of COPD and are having an effect on disease management and treatment outcomes. The link between COPD and comorbidities may be through systemic inflammation which opens up new treatment options.
本系列讲座由以下机构联合举办 (The Lecture Series is co-hosted by the following organizations)